Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

NCT01991561 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

390

Enrollment

INDUSTRY

Sponsor class

Conditions

Virus Diseases
RNA Virus Infections
Respiratory Tract Diseases
Respiratory Tract Infections

Interventions

BIOLOGICAL: Low dose of H5 VLP vaccine + Alhydrogel
BIOLOGICAL: Med dose of H5 VLP vaccine + Alhydrogel
BIOLOGICAL: High dose of H5 VLP vaccine + Alhydrogel
BIOLOGICAL: Low dose of H5 VLP vaccine + GLA-SE
BIOLOGICAL: High dose of H5 VLP vaccine + GLA-SE
BIOLOGICAL: Placebo comparator: Placebo

Sponsor

Medicago

Collaborators

[object Object]
[object Object]